arrow
R

Robert Błaszczyk

Medical University of Lublin
H指数:10
被引数:238

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Influence of renal function and dose of non-vitamin K antagonist oral anticoagulants on left atrial thrombus risk in patients with atrial fibrillation. Results from the multicenter LATTEE study

肾功能和非维生素K拮抗剂口服抗凝剂剂量对心房颤动患者左心房血栓风险的影响。多中心LATTEE研究的结果

2026-01-011
PRE
Changes in Anticoagulation Treatment and Associated Resolution or Persistence of Left Atrial Thrombus: Insights from LATTEE Registry

左心房血栓的消退或持续与抗凝治疗变化的关系:LATTEE注册研究启示

2025-11-010
PRE
Usability of CHA2DS2VASC score in predicting the effectiveness and safety of pharmacological cardioversion – data from the multicenter cardioversion with intravenous ANTazoline study

CHA2DS2VASC评分在预测药物复律有效性和安全性方面的可用性——来自多中心静脉注射ANTazoline复律研究的数据

2025-10-200
OAAI
Prevalence of left atrial thrombus in patients with atrial flutter in comparison to atrial fibrillation

左心房血栓在心房扑动患者中的患病率与心房颤动的比较

2025-03-250
PRE
Antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation and sex differences: Insights from the CANT II Study
2023-11-303
OA
Artificial intelligence in detecting left atrial appendage thrombus by transthoracic echocardiography and clinical features: the Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry
2023-07-1514
OA
Increased Body Mass Index and Risk of Left Atrial Thrombus in Nonvalvular Atrial Fibrillation Patients-Data from the Left Atrial Thrombus on Transesophageal Echocardiography (LATTEE) Registry
2022-09-040
OAAI
Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation or atrial flutter
2022-08-308
OA
Left Atrial Thrombus in Atrial Fibrillation/Flutter Patients in Relation to Anticoagulation Strategy: LATTEE Registry
2022-05-1113
OAAI
Efficacy and safety of antazoline for cardioversion of atrial fibrillation: propensity score matching analysis of a multicenter registry (CANT II Study)
2022-03-1614
OA
Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry
2021-10-082
OAAI
Hyperuricemia as a Marker of Reduced Left Ventricular Ejection Fraction in Patients with Atrial Fibrillation: Results of the POL-AF Registry Study
2021-04-228
OAAI
Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) Registry
2021-03-242
OAAI
Symptomatic and Asymptomatic Patients in the Polish Atrial Fibrillation (POL-AF) Registry
2021-03-059
OA
Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry

非维生素k拮抗剂口服抗凝剂治疗房颤的处方趋势: 波兰房颤 (pol-af) 注册结果

2020-11-057
OAAI